CH626344A5 - - Google Patents

Download PDF

Info

Publication number
CH626344A5
CH626344A5 CH877080A CH877080A CH626344A5 CH 626344 A5 CH626344 A5 CH 626344A5 CH 877080 A CH877080 A CH 877080A CH 877080 A CH877080 A CH 877080A CH 626344 A5 CH626344 A5 CH 626344A5
Authority
CH
Switzerland
Prior art keywords
compound
optically
turning
antipsychotic
new
Prior art date
Application number
CH877080A
Other languages
German (de)
English (en)
Inventor
David Carroll Remy
George Gal
Seemon Hayden Pines
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of CH626344A5 publication Critical patent/CH626344A5/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/38Halogen atoms or nitro radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40Oxygen atoms
    • C07D211/44Oxygen atoms attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/70Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74Oxygen atoms
    • C07D211/76Oxygen atoms attached in position 2 or 6
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F3/00Compounds containing elements of Groups 2 or 12 of the Periodic System
    • C07F3/02Magnesium compounds
CH877080A 1975-12-22 1980-11-26 CH626344A5 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/642,863 US4031222A (en) 1975-12-22 1975-12-22 Trifluoromethylthio (and sulfonyl) derivatives of cyproheptadine analogs

Publications (1)

Publication Number Publication Date
CH626344A5 true CH626344A5 (fr) 1981-11-13

Family

ID=24578354

Family Applications (7)

Application Number Title Priority Date Filing Date
CH1571276A CH625790A5 (fr) 1975-12-22 1976-12-14
CH876880A CH627167A5 (fr) 1975-12-22 1980-11-26
CH877080A CH626344A5 (fr) 1975-12-22 1980-11-26
CH877180A CH626345A5 (fr) 1975-12-22 1980-11-26
CH876980A CH626343A5 (fr) 1975-12-22 1980-11-26
CH877280A CH626346A5 (fr) 1975-12-22 1980-11-26
CH357381A CH631164A5 (de) 1975-12-22 1981-06-01 Verfahren zur herstellung von neuem 1-cyclopropylmethyl-4-(3-jod-5h-dibenzo(a,d)cyclohepten-5-yliden)piperidin.

Family Applications Before (2)

Application Number Title Priority Date Filing Date
CH1571276A CH625790A5 (fr) 1975-12-22 1976-12-14
CH876880A CH627167A5 (fr) 1975-12-22 1980-11-26

Family Applications After (4)

Application Number Title Priority Date Filing Date
CH877180A CH626345A5 (fr) 1975-12-22 1980-11-26
CH876980A CH626343A5 (fr) 1975-12-22 1980-11-26
CH877280A CH626346A5 (fr) 1975-12-22 1980-11-26
CH357381A CH631164A5 (de) 1975-12-22 1981-06-01 Verfahren zur herstellung von neuem 1-cyclopropylmethyl-4-(3-jod-5h-dibenzo(a,d)cyclohepten-5-yliden)piperidin.

Country Status (26)

Country Link
US (1) US4031222A (fr)
JP (1) JPS5278880A (fr)
AT (1) AT363936B (fr)
AU (1) AU506996B2 (fr)
BE (1) BE849678A (fr)
CA (1) CA1085823A (fr)
CH (7) CH625790A5 (fr)
DE (1) DE2657978C3 (fr)
DK (1) DK550976A (fr)
ES (6) ES454468A1 (fr)
FI (1) FI763545A (fr)
FR (1) FR2336133A1 (fr)
GB (1) GB1519080A (fr)
GR (1) GR62010B (fr)
HU (1) HU175018B (fr)
IE (1) IE44362B1 (fr)
IL (1) IL51103A (fr)
LU (1) LU76382A1 (fr)
NL (1) NL7613713A (fr)
NO (1) NO146359C (fr)
NZ (1) NZ182868A (fr)
PH (1) PH14088A (fr)
PL (4) PL116941B1 (fr)
PT (1) PT65956B (fr)
SE (1) SE7613796L (fr)
ZA (1) ZA767579B (fr)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4148903A (en) * 1977-07-28 1979-04-10 Merck & Co., Inc. Antipsychotic, antiserotonin and antihistaminic pyrrolo[2,1-b][3]benzazepines
US4132796A (en) * 1977-12-01 1979-01-02 Merck & Co., Inc. Antipsychotic 3-trifluoromethylsulfinyl analogs of cyproheptadine
US4285956A (en) * 1978-05-12 1981-08-25 Kefalas A/S Xanthene and thioxanthene derivatives, compositions thereof and treatment therewith
US4195091A (en) * 1978-11-15 1980-03-25 Merck & Co., Inc. Appetite stimulating pyrrolo[2,1-b][3]benzazepines
EP0012988B1 (fr) * 1979-01-02 1983-04-27 Merck & Co. Inc. Enantiomères lévogyres et dextrogyres de 3-halocyproheptadines, procédé pour leur préparation et composition pharmaceutique les contenant
EP0019797A1 (fr) * 1979-05-21 1980-12-10 Merck & Co. Inc. Enantiomères lévogyres et dextrogyres de 3-méthoxycyproheptadine et leurs analogues, procédé pour leur préparation et compositions pharmaceutiques à activité antipsychotique
US4220651A (en) * 1979-05-21 1980-09-02 Merck & Co., Inc. Antipsychotic levorotatory enantiomers of 3-halocyproheptadines, analogs and derivatives
US4275070A (en) * 1979-05-21 1981-06-23 Merck & Co., Inc. Antipsychotic pharmaceutical compositions of the levorotatory enantiomers of 3-methoxycyproheptadine and an analog thereof
US5231105A (en) * 1987-06-02 1993-07-27 Ajinomoto Co., Inc. Ethylamine derivatives and antihypertensives containing the same
US5250681A (en) * 1988-06-02 1993-10-05 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US5393890A (en) * 1988-06-02 1995-02-28 Ajinomoto Co., Inc. Piperidine derivatives and hypotensives containing the same
US4996321A (en) * 1990-02-26 1991-02-26 Merck & Co., Inc. Dibenzo[a,d]cycloheptenylidene compounds
US5114919A (en) * 1990-02-26 1992-05-19 Merck & Co., Inc. Adjuncts in cancer chemotherapy
US5021426A (en) * 1990-02-26 1991-06-04 Merck & Co., Inc. Method of traeting malaria with cyproheptadine derivatives
CN103130708B (zh) * 2011-12-01 2016-08-10 上海药明康德新药开发有限公司 一种n-叔丁氧羰基-4-硝基哌啶的制备方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3851059A (en) * 1970-02-05 1974-11-26 Merck & Co Inc Method for the stimulation of appetite in patients

Also Published As

Publication number Publication date
IL51103A (en) 1980-11-30
GB1519080A (en) 1978-07-26
PL194577A1 (fr) 1980-01-28
CH626346A5 (fr) 1981-11-13
AU506996B2 (en) 1980-01-31
BE849678A (fr) 1977-06-21
DE2657978B2 (de) 1980-06-04
DE2657978A1 (de) 1977-06-23
HU175018B (hu) 1980-04-28
ES466549A1 (es) 1978-10-01
PL122145B1 (en) 1982-06-30
ATA943376A (de) 1981-02-15
CH626343A5 (fr) 1981-11-13
US4031222A (en) 1977-06-21
PL116941B1 (en) 1981-07-31
DE2657978C3 (de) 1981-02-12
PT65956B (en) 1978-11-07
ZA767579B (en) 1978-08-30
FI763545A (fr) 1977-06-23
GR62010B (en) 1979-02-15
PL116346B1 (en) 1981-06-30
PH14088A (en) 1981-02-10
LU76382A1 (fr) 1977-06-28
NO146359B (no) 1982-06-07
ES454468A1 (es) 1978-04-16
CH627167A5 (fr) 1981-12-31
IE44362L (en) 1977-06-22
PL116947B1 (en) 1981-07-31
FR2336133A1 (fr) 1977-07-22
AU2052876A (en) 1978-06-22
PT65956A (en) 1977-01-01
IE44362B1 (en) 1981-11-04
SE7613796L (sv) 1977-06-23
CA1085823A (fr) 1980-09-16
ES466553A1 (es) 1978-10-01
ES466551A1 (es) 1978-10-01
ES466552A1 (es) 1978-10-01
DK550976A (da) 1977-06-23
IL51103A0 (en) 1977-02-28
ES466550A1 (es) 1978-10-01
FR2336133B1 (fr) 1978-11-17
NO764188L (fr) 1977-06-23
CH625790A5 (fr) 1981-10-15
AT363936B (de) 1981-09-10
NO146359C (no) 1982-09-15
JPS5278880A (en) 1977-07-02
NZ182868A (en) 1979-03-28
CH626345A5 (fr) 1981-11-13
NL7613713A (nl) 1977-06-24
CH631164A5 (de) 1982-07-30

Similar Documents

Publication Publication Date Title
DE60020994T2 (de) Neue verwendung sowie neue n-azabicycloamid-verbindungen
CH626344A5 (fr)
DE2437610A1 (de) Neue 5,9-beta-disubstituierte 2-tetrahydrofurfuryl-6,7-benzomorphane, deren saeureadditionssalze, ihre verwendung als arzneimittel und verfahren zu deren herstellung
DE10162375A1 (de) Bicyclische N-Aryl-amide
DD299431A5 (de) Neue 2-oxo-3,8-diaza-spiro[4,5]dekan-derivate und verfahren zur herstellung dieser verbindungen
EP0110073A1 (fr) Procédé de préparation de tétrahydropyridines
DE10211416A1 (de) Essig- und Propionsäureamide
EP0770082B1 (fr) Derives d'acide carboxylique de dioxo-thiopyrano-pyridine et leur utilisation comme medicaments
EP0158956B1 (fr) 4-(Nitrophényl)-tétrahydropyridines, leur procédé de préparation et leur application comme médicaments
DE3613180C2 (de) Verwendung von (-)-1beta-Ethyl-1alpha-(hydroxymethyl)-1,2,3,4,6,7,12,12balpha-octahydroindolo[2,3-a]chinolisin zur Behandlung von mit Durchblutungsstörungen verbundenen Krankheiten
AT391699B (de) Verfahren zur herstellung neuer 4-chloro substituierter furo-(3,4-c)-pyridinderivate
DE2632118A1 (de) Apovincaminolester und verfahren zu deren herstellung
DE10334724A1 (de) N-Biarylamide
CH625789A5 (fr)
DE2717001A1 (de) Arzneimittel mit antithrombotischer wirkung
DE10162442A1 (de) Monocyclische N-Aryl-amide
AT395852B (de) Imidazolyl-methyl-tetrahydrothiophenderivate
DE2520131A1 (de) Stickstoffhaltige polycyclische verbindungen und verfahren zu deren herstellung
DE102004002885B4 (de) Neue medizinisch einsetzbare Pyrrolalkaloide: Verfahren zu ihrer Isolierung, Synthese, sie enthaltende Arzneimittel und deren Verwendung
DE2541434A1 (de) 5-endo-(3-indolcarbonyloxy)-n- eckige klammer auf amino(niedrig)alkyl eckige klammer zu bicyclo eckige klammer auf 2.2.1 eckige klammer zu -heptan-2,3-di- endo-carbonsaeureimide, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DD210044A5 (de) Verfahren zur herstellung von trans-4ar-5-n-propyl-4,4a,5,6,7,8,8a,9-octahydro-1h(und 2h)pyrazolo(3,4-g)-chinolinen
AT281046B (de) Verfahren zur herstellung von neuen benz-epinderivaten und ihren saeureadditionssalzen
DE3731913A1 (de) Pharmazeutische praeparate enthaltend ein 7-diphenylmethylenbicycloheptan- oder 7-diphenylmethylenbicyclohepten-derivat, die verwendung dieser verbindungen als arzneimittel sowie neue 7-diphenylmethylenbicycloheptane und 7-diphenylmethylenbicloheptene und verfahren zu ihrer herstellung
DD272085A5 (de) Verfahren zur herstellung des rechtsdrehenden isomeren von alpha-(4,5,6,7-tetrahydro-(3,2-c)-thieno-5-pyridyl)-(2-chlor-phenyl)-essigsaeure--methylester
CH631175A5 (en) Processes for preparing a novel alkaloid of the vincamine type and salts thereof.

Legal Events

Date Code Title Description
PL Patent ceased